ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 11 filers reported holding ZEALAND PHARMA A S in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $87,000 | -13.9% | 6,705 | +3.1% | 0.00% | – |
Q1 2022 | $101,000 | -51.0% | 6,505 | -32.8% | 0.00% | – |
Q4 2021 | $206,000 | +6.7% | 9,683 | +47.8% | 0.00% | – |
Q3 2021 | $193,000 | +7.8% | 6,553 | +7.6% | 0.00% | – |
Q2 2021 | $179,000 | -16.4% | 6,090 | -8.8% | 0.00% | – |
Q1 2021 | $214,000 | -27.9% | 6,679 | -19.1% | 0.00% | – |
Q4 2020 | $297,000 | -7.5% | 8,256 | -1.2% | 0.00% | – |
Q3 2020 | $321,000 | +14.6% | 8,360 | +4.5% | 0.00% | – |
Q2 2020 | $280,000 | -43.2% | 8,003 | -43.9% | 0.00% | – |
Q1 2020 | $493,000 | +8.8% | 14,272 | +4.6% | 0.00% | – |
Q4 2019 | $453,000 | +109.7% | 13,641 | +59.8% | 0.00% | – |
Q3 2019 | $216,000 | +49.0% | 8,537 | +26.5% | 0.00% | – |
Q2 2019 | $145,000 | +18.9% | 6,749 | -5.6% | 0.00% | – |
Q1 2019 | $122,000 | +27.1% | 7,153 | -13.1% | 0.00% | – |
Q4 2018 | $96,000 | -38.1% | 8,231 | -12.4% | 0.00% | – |
Q3 2018 | $155,000 | +307.9% | 9,400 | +210.0% | 0.00% | – |
Q2 2018 | $38,000 | +8.6% | 3,032 | +32.0% | 0.00% | – |
Q1 2018 | $35,000 | +45.8% | 2,297 | +26.6% | 0.00% | – |
Q4 2017 | $24,000 | -59.3% | 1,814 | -40.4% | 0.00% | – |
Q3 2017 | $59,000 | – | 3,046 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 48,957 | $631,000 | 0.10% |
GOLDMAN SACHS GROUP INC | 500,916 | $6,517,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 220,523 | $2,869,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 100 | $1,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
US BANCORP \DE\ | 509 | $7,000 | 0.00% |
CREDIT SUISSE AG/ | 285 | $4,000 | 0.00% |
MORGAN STANLEY | 6,705 | $87,000 | 0.00% |
UBS Group AG | 351 | $4,000 | 0.00% |
JANE STREET GROUP, LLC | 23,976 | $312,000 | 0.00% |